February 28, 2018 / 12:08 PM / 4 months ago

BRIEF-Amicus Therapeutics Sees FY 2018 Revenue $75 Million To $85 Million

Feb 28 (Reuters) - Amicus Therapeutics Inc:

* AMICUS THERAPEUTICS ANNOUNCES FULL-YEAR 2017 FINANCIAL RESULTS AND 2018 CORPORATE UPDATES

* SEES FY 2018 REVENUE $75 MILLION TO $85 MILLION

* DEVELOP AND EXPAND PRECLINICAL PIPELINE TO ENSURE AT LEAST ONE NEW CLINICAL PROGRAM IN 2019

* ON TRACK TO ACHIEVE FY18 REVENUE GUIDANCE OF $75M-$85M

* REITERATED FULL-YEAR 2018 REVENUE AND NET CASH SPEND GUIDANCE

* CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES TOTALED $358.6 MILLION AT DECEMBER 31, 2017

* FY2018 REVENUE VIEW $86.8 MILLION — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below